Cardiol Therapeutics Inc (NASDAQ:CRDL) price on Thursday, July 03, rose 10.79% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.54.
A look at the stock’s price movement, the close in the last trading session was $1.39, moving within a range at $1.42 and $1.54. The beta value (5-Year monthly) was 0.763. Turning to its 52-week performance, $2.63 and $0.77 were the 52-week high and 52-week low respectively. Overall, CRDL moved 17.56% over the past month.
Cardiol Therapeutics Inc’s market cap currently stands at around $127.28 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CRDL is a 50% Buy. On the other hand, the stock is on average a 50% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend CRDL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CRDL’s current price about 10.39% and 23.52% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 63.27, while 7-day volatility ratio is 7.87% and 7.19% in the 30-day chart. Further, Cardiol Therapeutics Inc (CRDL) has a beta value of 1.04. Analysts have given the company’s stock an average 52-week price target of $8, forecast between a low of $8 and high of $8. Looking at the price targets, the low is -419.48% off current price level while to achieve the yearly target high, price needs to move -419.48%. Nonetheless, investors will most likely welcome a -419.48% jump to $8 which is the analysts’ median price.
If we refocus on Cardiol Therapeutics Inc (NASDAQ:CRDL), historical trading data shows that trading volumes averaged 0.21 over the past 10 days and 192.90K over the past 3 months. The company’s latest data on shares outstanding shows there are 82.61 million shares.
The 4.78% of Cardiol Therapeutics Inc’s shares are in the hands of company insiders while institutional holders own 9.46% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.91 million on 2025-06-13, giving us a short ratio of 8.79. The data shows that as of 2025-06-13 short interest in Cardiol Therapeutics Inc (CRDL) stood at 240.0 of shares outstanding, with shares short rising to 1.84 million registered in 2025-05-15. Current price change has pushed the stock -23.00% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CRDL stock continues to rise going into the next quarter.
